Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jul 15;35(9):1497-1498.
doi: 10.1097/QAD.0000000000002885.

Pediatric liquid 'single tablet regimens' for HIV-a call to action

Dean L Winslow  1
Affiliations
Comment

Pediatric liquid 'single tablet regimens' for HIV-a call to action

Dean L Winslow. AIDS. .
No abstract available

PubMed Disclaimer

Comment on

  • Etravirine in treatment-experienced HIV-1-infected children 1 year to less than 6 years of age.
    MacBrayne CE, Rutstein RM, Wiznia AA, Graham B, Alvero CG, Fairlie L, Lypen K, George KH, Townley E, Moye J Jr, Costello DG, Reding CA, Barroso Hofer C, Crauwels HM, Woot de Trixhe X, Tambuyzer L, Vanveggel S, Opsomer M, Kiser JJ; and the IMPAACT P1090 Protocol Team. MacBrayne CE, et al. AIDS. 2021 Jul 15;35(9):1413-1421. doi: 10.1097/QAD.0000000000002902. AIDS. 2021. PMID: 33831904 Free PMC article.

References

    1. Joshi VV, Oleske JM, Minnefor AB, Saad S, Klein KM, Singh R, et al. Pathologic pulmonary findings in children with the acquired immunodeficiency syndrome: a study of ten cases . Hum Pathol 1985; 16:241–246.
    1. Pollock L, Else L, Poerksen G, Molyneux E, Moons P, Walker S, et al. Pharmacokinetics of nevirapine in HIV-infected children with and without malnutrition receiving divided adult fixed-dose combination tablets . J Antimicrob Chemother 2009; 64:1251–1259.
    1. MacBrayne CE, Rutstein RM, Wiznia AA, Graham B, Alvero CG, Fairlie L, et al. the IMPAACT P1090 Protocol Team. Etravirine in treatment-experienced HIV-1-infected children 1 year to less than 6 years of age . AIDS 2021; 35:1413–1421.
    1. Andries K, Azijn H, Thielemans T, Ludovici D, Kukla M, Heeres J, et al. TMC125, a novel next-generation non-nucleoside reverse transcriptase inhibitor active against non-nucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1 . Antimicrob Agents Chemother 2004; 48:4680–4686.
    1. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. Department of Health and Human Services. https://clinicalinfo.hiv.gov/en/guidelines/adult-and-adolescent-arv/what...